Clinical Trial Update: A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers [Phase 3]

View source ↗

Summary

This update reports a comparability study comparing the Phase 3 production lot and a single commercial lot of NicVAX in healthy adult smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NicVAX (nicotine vaccine)

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Smoking | Phase 3 | Status: COMPLETED